Live News EQUITY M impact Jun 22, 2026, 05:28 PM UTC

MPLT: Needham Raises PT

Needham maintains buy rating on MapLight Therapeutics and raises price target to $42

SQUAWKNEWS Updated Jun 22, 2026, 05:31 PM UTC

Needham Maintains Buy on MapLight Therapeutics, Raises Price Target to $42